PAPER Akoury E, Pickhardt M, Gajda M, Biernat J, Mandelkow E, Zweckstetter M

Mechanistic basis of phenothiazine-driven inhibition of tau aggregation.

Angew Chem Int Ed Engl. 2013 Mar 18;52(12):3511-5. PubMed: 23401175

PAPER Zhang B, Tang XC, Zhang HY

Alternations of central insulin-like growth factor-1 sensitivity in APP/PS1 transgenic mice and neuronal models.

J Neurosci Res. 2013 May;91(5):717-25. PubMed: 23401344

PAPER Garai K, Frieden C

Quantitative analysis of the time course of Aβ oligomerization and subsequent growth steps using tetramethylrhodamine-labeled Aβ.

Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3321-6. PubMed: 23401512

PAPER He J, Li X, Yang J, Huang J, Fu X, Zhang Y, Fan H

The association between the methionine/valine (M/V) polymorphism (rs1799990) in the PRNP gene and the risk of Alzheimer disease: an update by meta-analysis.

J Neurol Sci. 2013 Mar 15;326(1-2):89-95. PubMed: 23399523

PAPER Kingwell K

Alzheimer disease: modified Salmonella toxin combats Alzheimer disease in mouse model.

Nat Rev Neurol. 2013 Mar;9(3):120. PubMed: 23399645

PAPER Chételat G

Alzheimer disease: Aβ-independent processes-rethinking preclinical AD.

Nat Rev Neurol. 2013 Mar;9(3):123-4. PubMed: 23399647

PAPER Ghochikyan A, Davtyan H, Petrushina I, Hovakimyan A, Movsesyan N, Davtyan A, Kiyatkin A, Cribbs DH, Agadjanyan MG

Refinement of a DNA based Alzheimer's disease epitope vaccine in rabbits.

Hum Vaccin Immunother. 2013 Feb 11;9(5) PubMed: 23399748

PAPER Zhang ZY, Schluesener HJ

Oral administration of histone deacetylase inhibitor MS-275 ameliorates neuroinflammation and cerebral amyloidosis and improves behavior in a mouse model.

J Neuropathol Exp Neurol. 2013 Mar;72(3):178-85. PubMed: 23399896

PAPER Chapuis J, Hansmannel F, Gistelinck M, Mounier A, Van Cauwenberghe C, Kolen KV, Geller F, Sottejeau Y, Harold D, Dourlen P, Grenier-Boley B, Kamatani Y, Delepine B, Demiautte F, Zelenika D, Zommer N, Hamdane M, Bellenguez C, Dartigues JF, Hauw JJ, Letronne F, Ayral AM, Sleegers K, Schellens A, Broeck LV, Engelborghs S, De Deyn PP, Vandenberghe R, O'Donovan M, Owen M, Epelbaum J, Mercken M, Karran E, Bantscheff M, Drewes G, Joberty G, Campion D, Octave JN, Berr C, Lathrop M, Callaerts P, Mann D, Williams J, Buée L, Dewachter I, Van Broeckhoven C, Amouyel P, Moechars D, Dermaut B, Lambert JC, GERAD consortium

Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology.

Mol Psychiatry. 2013 Nov;18(11):1225-34. Epub 2013 Feb 12 PubMed: 23399914

PAPER Bennett DA

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.

Neurology. 2013 Feb 12;80(7):690. PubMed: 23400321

PAPER Marchant NL, Reed BR, Sanossian N, Madison CM, Kriger S, Dhada R, Mack WJ, Decarli C, Weiner MW, Mungas DM, Chui HC, Jagust WJ

The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction.

JAMA Neurol. 2013 Apr 1;70(4):488-95. PubMed: 23400560

PAPER Zlokovic BV

Cerebrovascular effects of apolipoprotein e: implications for Alzheimer disease.

JAMA Neurol. 2013 Apr 1;70(4):440-4. PubMed: 23400708

PAPER Praticò D

Antioxidants for Alzheimer disease.

JAMA Neurol. 2013 Feb;70(2):270. PubMed: 23400723

PAPER Johnson DY, Dunkelberger DL, Henry M, Haman A, Greicius MD, Wong K, Dearmond SJ, Miller BL, Gorno-Tempini ML, Geschwind MD

Sporadic Jakob-Creutzfeldt disease presenting as primary progressive aphasia.

JAMA Neurol. 2013 Feb;70(2):254-7. PubMed: 23400721

PAPER Galasko DR, Aisen P

Antioxidants for Alzheimer disease-reply.

JAMA Neurol. 2013 Feb;70(2):270-1. PubMed: 23400724